Variant report

Variant	nsv875013
Chromosome Location	chr2:128177974-128183145
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:203)
CpG islands
(count:428)
Chromatin interactive
region (count:6)
LncRNA
region (count:0)
Mature miRNA
region (count: 2)
miRNA target
sites (count:0)

(count:203 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr2:128179389-128179419	K562	blood:	n/a	n/a
2	BHLHE40	chr2:128180528-128180738	A549	lung:	n/a	n/a
3	BHLHE40	chr2:128180513-128180785	K562	blood:	n/a	n/a
4	BHLHE40	chr2:128180580-128180672	GM12878	blood:	n/a	n/a
5	BRCA1	chr2:128181187-128181452	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr2:128181012-128181341	Hela-S3	cervix:	n/a	n/a
7	CEBPB	chr2:128181008-128181219	A549	lung:	n/a	n/a
8	CHD2	chr2:128180216-128180612	H1-hESC	embryonic stem cell:	n/a	n/a
9	CHD2	chr2:128181092-128181333	Hela-S3	cervix:	n/a	chr2:128181309-128181319
10	CREB1	chr2:128180234-128180864	H1-hESC	embryonic stem cell:	n/a	n/a
11	CREB1	chr2:128180798-128181400	A549	lung:	n/a	n/a
12	CTBP2	chr2:128180052-128181455	H1-hESC	embryonic stem cell:	n/a	n/a
13	CTCF	chr2:128181580-128181730	HMF	breast:	n/a	n/a
14	CTCF	chr2:128181287-128181302	MCF-7	breast:	n/a	n/a
15	CTCF	chr2:128180820-128180970	GM12871	blood:	n/a	n/a
16	CTCF	chr2:128180880-128181030	SK-N-SH_RA	brain:	n/a	n/a
17	CTCF	chr2:128181320-128181470	HBMEC	blood vessel:	n/a	n/a
18	CTCF	chr2:128182800-128182950	A549	lung:	n/a	n/a
19	CTCF	chr2:128180800-128180950	GM12866	blood:	n/a	n/a
20	CTCF	chr2:128181360-128181510	NHDF-neo	bronchial:	n/a	n/a
21	CTCF	chr2:128181160-128181310	BJ	skin:	n/a	chr2:128181243-128181256 chr2:128181250-128181263
22	CTCF	chr2:128182792-128182969	A549	lung:	n/a	n/a
23	CTCF	chr2:128181340-128181490	NB4	blood:	n/a	n/a
24	CTCF	chr2:128182800-128182950	HBMEC	blood vessel:	n/a	n/a
25	CTCF	chr2:128181300-128181450	HBMEC	blood vessel:	n/a	n/a
26	CTCF	chr2:128182800-128182950	HepG2	liver:	n/a	n/a
27	CTCF	chr2:128181120-128181270	HCPEpiC	choroid plexus:	n/a	chr2:128181243-128181256 chr2:128181250-128181263
28	CTCF	chr2:128182674-128183020	MCF-7	breast:	n/a	n/a
29	CTCF	chr2:128180880-128180963	GM10248	blood:	n/a	n/a
30	CTCF	chr2:128182740-128182890	HUVEC	blood vessel:	n/a	n/a
31	CTCF	chr2:128181680-128181830	HUVEC	blood vessel:	n/a	n/a
32	CTCF	chr2:128181520-128181670	HCFaa	heart:	n/a	n/a
33	CTCF	chr2:128181480-128181630	HPAF	blood vessel:	n/a	n/a
34	CTCF	chr2:128182840-128182925	ProgFib	skin:	n/a	n/a
35	CTCF	chr2:128181279-128181333	MCF-7	breast:	n/a	n/a
36	CTCF	chr2:128182700-128182850	HCPEpiC	choroid plexus:	n/a	n/a
37	CTCF	chr2:128181165-128181370	NHEK	skin:	n/a	chr2:128181243-128181256 chr2:128181250-128181263
38	CTCF	chr2:128180880-128181030	Caco-2	colon:	n/a	n/a
39	CTCF	chr2:128181240-128181390	WERI-Rb-1	eye:	n/a	chr2:128181243-128181256 chr2:128181250-128181263
40	CTCF	chr2:128181260-128181410	GM12874	blood:	n/a	n/a
41	CTCF	chr2:128181500-128181650	AG09319	gingival:	n/a	n/a
42	CTCF	chr2:128181260-128181410	Caco-2	colon:	n/a	n/a
43	CTCF	chr2:128181540-128181690	HCT-116	colon:	n/a	n/a
44	CTCF	chr2:128180882-128181012	H1-hESC	embryonic stem cell:	n/a	n/a
45	CTCF	chr2:128180840-128180990	GM06990	blood:	n/a	n/a
46	CTCF	chr2:128181520-128181670	AG04450	lung:	n/a	n/a
47	CTCF	chr2:128180840-128180990	NB4	blood:	n/a	n/a
48	CTCF	chr2:128181080-128181230	A549	lung:	n/a	n/a
49	CTCF	chr2:128181360-128181510	A549	lung:	n/a	n/a
50	CTCF	chr2:128181220-128181370	NHEK	skin:	n/a	chr2:128181243-128181256 chr2:128181250-128181263

(count:428 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:128182794-128182844	U87	brain:	n/a
2	chr2:128182794-128182844	U87	brain:	n/a
3	chr2:128180646-128180696	IMR90	lung:	fetal
4	chr2:128182794-128182844	H1-hESC	embryonic stem cell:	embryo
5	chr2:128180829-128180879	ovcar-3	ovarian:	n/a
6	chr2:128180959-128181009	ECC-1	luminal epithelium:	n/a
7	chr2:128182794-128182844	HNPCEpiC	eye:	n/a
8	chr2:128180646-128180696	AoSMC	blood vessel:	n/a
9	chr2:128180959-128181009	RPTEC	kidney:	n/a
10	chr2:128182794-128182844	SKMC	muscle:	n/a
11	chr2:128181325-128181375	MCF10A-Er-Src	breast:	n/a
12	chr2:128182794-128182844	HRCEpiC	kidney:	n/a
13	chr2:128181313-128181363	GM12891	blood:	n/a
14	chr2:128180488-128180538	HepG2	liver:	n/a
15	chr2:128180488-128180538	PANC-1	pancreas:	n/a
16	chr2:128180829-128180879	Jurkat	blood:	n/a
17	chr2:128180959-128181009	NH-A	brain:	n/a
18	chr2:128180959-128181009	HRPEpiC	eye:	n/a
19	chr2:128180488-128180538	NHDF-neo	bronchial:	n/a
20	chr2:128180646-128180696	HIPEpiC	eye:	n/a
21	chr2:128180488-128180538	HL-60	blood:	n/a
22	chr2:128182794-128182844	PFSK-1	brain:	n/a
23	chr2:128182794-128182844	IMR90	lung:	fetal
24	chr2:128180488-128180538	GM12891	blood:	n/a
25	chr2:128180488-128180538	GM12892	blood:	n/a
26	chr2:128180959-128181009	SKMC	muscle:	n/a
27	chr2:128181313-128181363	ECC-1	luminal epithelium:	n/a
28	chr2:128180488-128180538	GM06990	blood:	n/a
29	chr2:128182794-128182844	HCF	heart:	n/a
30	chr2:128182794-128182844	NHBE	bronchial:	n/a
31	chr2:128180488-128180538	HRCEpiC	kidney:	n/a
32	chr2:128180646-128180696	BJ	skin:	n/a
33	chr2:128182794-128182844	Hela-S3	cervix:	n/a
34	chr2:128180829-128180879	HPAEpiC	pulmonary alveolar:	n/a
35	chr2:128181325-128181375	HCT-116	colon:	n/a
36	chr2:128181325-128181375	A549	lung:	n/a
37	chr2:128180646-128180696	HepG2	liver:	n/a
38	chr2:128180959-128181009	HCF	heart:	n/a
39	chr2:128180488-128180538	HCF	heart:	n/a
40	chr2:128181325-128181375	ECC-1	luminal epithelium:	n/a
41	chr2:128180829-128180879	CMK	blood:	n/a
42	chr2:128180646-128180696	PrEC	prostate:	n/a
43	chr2:128181325-128181375	SK-N-SH_RA	brain:	n/a
44	chr2:128182794-128182844	SAEC	small airway:	n/a
45	chr2:128180959-128181009	SK-N-SH	brain:	n/a
46	chr2:128180959-128181009	HCT-116	colon:	n/a
47	chr2:128180829-128180879	AG09309	skin:	n/a
48	chr2:128181313-128181363	HEEpiC	esophagus:	n/a
49	chr2:128180488-128180538	NH-A	brain:	n/a
50	chr2:128181325-128181375	Jurkat	blood:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:128143841..128146885-chr2:128179410..128184717,5	MCF-7	breast:
2	chr2:128143986..128147167-chr2:128178825..128181533,4	MCF-7	breast:
3	chr2:128182670..128185856-chr2:128186426..128188335,3	K562	blood:
4	chr2:128178778..128180626-chr2:128184042..128185706,2	MCF-7	breast:
5	chr2:128173888..128177059-chr2:128178517..128180558,4	K562	blood:
6	chr2:128172446..128176144-chr2:128177649..128179573,3	MCF-7	breast:

No data

miRNA name	Chromosome Location	mirBase accession
hsa-miR-4783-3p	chr2:128181122-128181144	MIMAT0019947
hsa-miR-4783-5p	chr2:128181162-128181182	MIMAT0019946

No data

Variant related genes	Relation type
MIR4783	TF binding region
PROC	TF binding region
MIR4783	CpG island
PROC	CpG island
ENSG00000115718	chromatin interactions
ENSG00000236682	chromatin interactions
ENSG00000169967	chromatin interactions

Extended variants
information (count: 221 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:221 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2069910	chr2:128177974-128177975	Enhancers Genic enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs34405291	chr2:128177991-128177992	Enhancers Genic enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs113527505	chr2:128178003-128178004	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs559894756	chr2:128178009-128178010	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs2069911	chr2:128178047-128178048	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs552514538	chr2:128178103-128178104	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs2069912	chr2:128178191-128178192	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
8	rs115049674	chr2:128178195-128178196	Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs548120331	chr2:128178200-128178201	Weak transcription Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs372032851	chr2:128178214-128178215	Weak transcription Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs72167341	chr2:128178241-128178242	Weak transcription Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs2069913	chr2:128178259-128178260	Weak transcription Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
13	rs536393690	chr2:128178261-128178262	Weak transcription Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs2069914	chr2:128178272-128178273	Weak transcription Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
15	rs2854697	chr2:128178282-128178283	Weak transcription Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs572912448	chr2:128178328-128178329	Weak transcription Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs538615903	chr2:128178365-128178366	Weak transcription Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs2069915	chr2:128178378-128178379	Weak transcription Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs575564121	chr2:128178380-128178381	Weak transcription Transcr. at gene 5' and 3' Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs544491905	chr2:128178410-128178411	Weak transcription Transcr. at gene 5' and 3' Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs2069916	chr2:128178415-128178416	Weak transcription Transcr. at gene 5' and 3' Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
22	rs574927662	chr2:128178523-128178524	Weak transcription Transcr. at gene 5' and 3' Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs2069917	chr2:128178527-128178528	Weak transcription Transcr. at gene 5' and 3' Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs116428211	chr2:128178535-128178536	Weak transcription Transcr. at gene 5' and 3' Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs532165569	chr2:128178536-128178537	Weak transcription Transcr. at gene 5' and 3' Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs545842114	chr2:128178540-128178541	Weak transcription Transcr. at gene 5' and 3' Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs576663389	chr2:128178589-128178590	Weak transcription Transcr. at gene 5' and 3' Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs141446713	chr2:128178597-128178598	Weak transcription Transcr. at gene 5' and 3' Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs531677728	chr2:128178705-128178706	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs548461557	chr2:128178711-128178712	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs547483675	chr2:128178741-128178742	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs150848560	chr2:128178746-128178747	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs566601728	chr2:128178747-128178748	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs538727437	chr2:128178758-128178759	Weak transcription Enhancers Genic enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs371581716	chr2:128178813-128178814	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs138057813	chr2:128178842-128178843	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
37	rs199825649	chr2:128178843-128178844	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
38	rs552714462	chr2:128178878-128178879	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
39	rs199514227	chr2:128178906-128178907	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs369504169	chr2:128178913-128178914	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs141040323	chr2:128178926-128178927	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs376049280	chr2:128178948-128178949	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs574949343	chr2:128178958-128178959	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs121918148	chr2:128178973-128178974	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs201463891	chr2:128178986-128178987	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs199469481	chr2:128178996-128178997	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs568473236	chr2:128178997-128178998	Weak transcription Bivalent Enhancer Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs121918149	chr2:128179014-128179015	Bivalent Enhancer Weak transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs199469482	chr2:128179030-128179031	Bivalent Enhancer Weak transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs528055589	chr2:128179040-128179041	Bivalent Enhancer Weak transcription Genic enhancers Enhancers	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myxofibrosarcoma	16751306	CNVD
Breast cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Mowat-Wilson syndrome	21572526	CNVD
Disorders of sex development	21048976	CNVD
epilepsy	18472482	CNVD
Ewing''s sarcoma	17952124	CNVD
Hepatocellular carcinoma	16750200	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
lymphocytic leukemia	21291569	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Colorectal cancer	16272173	CNVD
myoclonus epilepsy	18472482	CNVD
Benign familial neonatal-infantile seizures	18472482	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Mental retardation	17621639	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	18632612	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Medulloblastoma	16968546	CNVD
Neurocytoma	17123091	CNVD
Developmental delay	21147756	CNVD
Breast cancer	21364760	CNVD
Prostate cancer	22341455	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:368 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:128174000-128180600	Weak transcription	Right Atrium	heart
2	chr2:128174800-128180400	Weak transcription	Spleen	Spleen
3	chr2:128175000-128180000	Weak transcription	Primary B cells from cord blood	blood
4	chr2:128176200-128178000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
5	chr2:128176200-128179800	Weak transcription	Dnd41	blood
6	chr2:128176400-128180400	Weak transcription	Pancreas	Pancrea
7	chr2:128176800-128179800	Weak transcription	Gastric	stomach
8	chr2:128177000-128178000	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
9	chr2:128177000-128178400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
10	chr2:128177200-128178000	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr2:128177200-128178000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
12	chr2:128177400-128178600	Transcr. at gene 5' and 3'	HepG2	liver
13	chr2:128177600-128178200	Flanking Active TSS	Liver	Liver
14	chr2:128177800-128179800	Enhancers	Fetal Thymus	thymus
15	chr2:128177800-128180600	Weak transcription	A549	lung
16	chr2:128178000-128178600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr2:128178000-128179000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
18	chr2:128178200-128178600	Transcr. at gene 5' and 3'	Liver	Liver
19	chr2:128178600-128178800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr2:128178600-128179600	Genic enhancers	HepG2	liver
21	chr2:128178600-128180200	Genic enhancers	Liver	Liver
22	chr2:128178800-128179600	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr2:128179000-128181000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
24	chr2:128179400-128180400	Enhancers	Primary hematopoietic stem cells short term culture	blood
25	chr2:128179600-128180000	Strong transcription	HepG2	liver
26	chr2:128179600-128181400	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr2:128179800-128180000	Bivalent/Poised TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr2:128179800-128180000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
29	chr2:128179800-128180000	Bivalent Enhancer	Esophagus	oesophagus
30	chr2:128179800-128180000	Enhancers	Dnd41	blood
31	chr2:128179800-128180000	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
32	chr2:128179800-128180200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
33	chr2:128179800-128180400	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
34	chr2:128179800-128180400	Bivalent Enhancer	Primary B cells from peripheral blood	blood
35	chr2:128179800-128180400	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
36	chr2:128179800-128180400	Bivalent Enhancer	Fetal Thymus	thymus
37	chr2:128179800-128180800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
38	chr2:128179800-128181000	Active TSS	Gastric	stomach
39	chr2:128180000-128180200	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
40	chr2:128180000-128180200	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
41	chr2:128180000-128180200	Bivalent/Poised TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
42	chr2:128180000-128180200	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
43	chr2:128180000-128180200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
44	chr2:128180000-128180200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
45	chr2:128180000-128180200	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
46	chr2:128180000-128180200	Flanking Bivalent TSS/Enh	Primary neutrophils fromperipheralblood	blood
47	chr2:128180000-128180200	Bivalent Enhancer	Primary hematopoietic stem cells	blood
48	chr2:128180000-128180200	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin01	Skin
49	chr2:128180000-128180200	Flanking Active TSS	Brain Angular Gyrus	brain
50	chr2:128180000-128180200	Bivalent Enhancer	Fetal Brain Female	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links